Nautilus Biotechnology, Inc. (NAUT)
NASDAQ·Healthcare·Biotechnology
$2.58
+0.39%
Mkt Cap $331.60M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $1.29M | — | — | -$0.14 | -$0.11 | +21.43% | — | — |
| Q4 2025 Oct 27, 2025 | — | — | — | -$0.15 | -$0.11 | +26.67% | — | — |
| Q3 2025 Jul 31, 2025 | — | — | — | -$0.15 | -$0.12 | +22.58% | — | — |
| Q2 2025 Apr 29, 2025 | — | — | — | -$0.14 | -$0.13 | +7.14% | — | — |
| Q1 2025 Feb 26, 2025 | — | $9.60M | — | -$0.16 | -$0.14 | +12.50% | — | — |
| Q4 2024 Oct 29, 2024 | — | — | — | -$0.17 | -$0.13 | +23.53% | — | — |
| Q3 2024 Jul 30, 2024 | — | — | — | -$0.16 | -$0.14 | +12.50% | — | — |
| Q2 2024 Apr 30, 2024 | — | — | — | -$0.16 | -$0.15 | +6.25% | — | — |
| Q1 2024 Feb 28, 2024 | — | $8.21M | — | -$0.16 | -$0.14 | +12.50% | — | — |
| Q4 2023 Oct 31, 2023 | — | — | — | -$0.18 | -$0.13 | +27.78% | — | — |
| Q3 2023 Aug 2, 2023 | — | — | — | -$0.17 | -$0.13 | +23.53% | — | — |
| Q2 2023 May 2, 2023 | — | — | — | -$0.16 | -$0.12 | +25.00% | — | — |
| Q1 2023 Feb 23, 2023 | — | — | — | -$0.15 | -$0.11 | +26.67% | — | — |
| Q4 2022 Nov 1, 2022 | — | — | — | -$0.14 | -$0.11 | +21.43% | — | — |
| Q3 2022 Aug 2, 2022 | — | — | — | -$0.17 | -$0.12 | +29.41% | — | — |
| Q2 2022 May 3, 2022 | $166.67K | — | — | -$0.15 | -$0.13 | +13.33% | — | — |
| Q1 2022 Feb 24, 2022 | — | — | — | -$0.15 | -$0.13 | +13.33% | — | — |
| Q4 2021 Nov 2, 2021 | — | — | — | -$0.11 | -$0.12 | -9.09% | — | — |
| Q3 2021 Aug 10, 2021 | — | — | — | -$0.09 | -$0.19 | -111.11% | — | — |
| Q2 2021 Jun 10, 2021 | — | — | — | — | -$0.25 | — | — | — |